Discrepancies between in silico and in vitro data in the functional analysis of a breast cancer-associated polymorphism in the XRCC6/Ku70 gene

Molecular Medicine Reports

Volumn 1, Issue 6, 2008, Pages 805-812

  Marras, Emanuela ^a   Willems, Petra ^b   Vandersickel, Veerle ^a   Ceriani, Isabella ^b   Thierens, Hubert ^b   Vral, Anne ^b   Perletti, Gianpaolo ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Alternative promoter; Ku70; Non homologous end joining; Splicing; XRCC6

Indexed keywords

KU ANTIGEN; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING 6 PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER PATIENT; CELL CULTURE; COMPUTER MODEL; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA SPLICING; ENZYME ACTIVITY; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; RNA SPLICING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 69249137494     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000032     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M and Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592, 2007.
3. Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L and Vral A: Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87: 1379-1385, 2002. (Pubitemid 36044311)
4. Baeyens A, van den Broecke R, Makar A, Thierens H, De Ridder L and Vral A: Chromosomal radiosensitivity in breast cancer patients: Influence of age of onset of the disease. Oncol Rep 13: 347-353, 2005.
5. Jones L, Scott D, Cowan R and Roberts S: Abnormal radiosensitivity of lymphocytes from breast-cancer patients with excessive normal tissue-damage after radiotherapy - chromosome-aberrations after low dose-rate irradiation. Int J Radiat Biol 67: 519-528, 1995.
6. Scott, D, Barber J, Levine E, Burrill W and Roberts S: Radiationinduced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 77: 614-620, 1998. (Pubitemid 28059469)
7. Scott, D, Barber J, Spreadborough A, Burrill W and Roberts S: Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol 75: 1-10, 1999. (Pubitemid 29057038)
8. Ralhan R, Kaur J, Kreienberg R and Wiesmüller L: Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett 248: 1-17, 2007. (Pubitemid 46319342)
9. Dapic V, Carvalho MA and Monteiro AN: Breast cancer susceptibility and the DNA damage response. Cancer Control 12: 127-136, 2005. (Pubitemid 40647057)
10. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton D, Evans C, Deacon J and Stratton M: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91: 943-949, 1999. (Pubitemid 29272520)
11. Rebbeck T: Inherited genetic predisposition in breast cancer - a population-based perspective. Cancer 86 (Suppl S): 2493-2501, 1999. (Pubitemid 30007532)
12. Fu Y, Yu J, Cheng T, Lou M, Hsu G, Wu C, Chen S, Wu H, Wu P and Shen C: Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: A multigenic study on cancer susceptibility. Cancer Res 63: 2440-2446, 2003. (Pubitemid 36605181)
13. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA and Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8: 843-854, 1999. (Pubitemid 29508718)
14. Bau D, Fu Y, Chen S, Cheng T, Yu J, Wu P and Shen C: Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res 64: 5013-5019, 2004. (Pubitemid 38924550)
15. Bau D, Mau Y, Ding S, Wu P and Shen C: DNA double-strand break repair capacity and risk of breast cancer. Carcinogenesis 28: 1726-1730, 2007. (Pubitemid 47289034)
16. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BAJ, Pharoah PDP and Dunning A: Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11: 1399-1407, 2002. (Pubitemid 34746540)
17. Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, van den Broecke R, Makar A, Marras E, Perletti G, Thierens H and Vral A: Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosomes Cancer 47: 137-148, 2008.
18. Roy D, Cai Q, Felty Q and Narayan S: Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev 10: 235-257, 2007. (Pubitemid 47057178)
19. Valerie K and Povirk L: Regulation and mechanisms of mammalian double-strand break repair Oncogene 22: 5792-5812, 2003.
20. Burma S, Chen BP and Chen DJ: Role of non-homologous end joining in maintaining genomic integrity. DNA Repair 5: 1042-1048, 2006. (Pubitemid 44291616)
21. Iliakis, G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, Wu W, Guan J, Terdouzi G and Pantelias G: Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 104: 14-20, 2004. (Pubitemid 38721048)
22. Tsai YY, Bau DT, Chiang CC, Cheng YW, Tseng SH and Tsai FJ: Pterygium and genetic polymorphism of DNA double strand break repair gene Ku70/XRCC6. Mol Vis 13: 1436-1440, 2007.
23. Shapiro MB and Senapathy P: RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15: 7155-7174, 1987.
24. Rogan PK, Faux BM and Schneider TD: Information analysis of human splice site mutations. Hum Mutat 12: 153-171, 1998.
25. Khan SG, Levy HL, Legerski R, Quackenbush E, Reardon JT, Emmert S, Sancar A, Li L, Schneider TD, Cleaver JE and Kraemer KH: Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. J Invest Dermatol 111: 791-796, 1998. (Pubitemid 28509320)
26. Steitz JA: Splicing takes a holliday. Science 257: 888-889, 1992.
27. Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, Nagawa H and Suzuki N: Up-regulation of DNAdependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25: 461-468, 2004.
28. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, Takahashi-Fujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T and Sugano S: Diversification of transcriptional modulation: largescale identification and characterization of putative alternative promoters of human genes. Genome Res 16: 55-65, 2006. (Pubitemid 43048934)
29. Bau DT, Tseng HC, Wang CH, Chiu CF, Hua CH, Wu CN, Liang SY, Wang CL, Tsai CW and Tsai MH: Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Oral Oncol, May 16, 2008 (Epub ahead of print).
30. Pearman AT, Chou WY, Bergman KD, Pulumati MR and Partridge NC. Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE. J Biol Chem 271: 25715-25721, 1996.